Physician

Asheesh Tewari, MD

According to 2025 Medicare claims, Asheesh Tewari, MD (NPI: 1043248032) practices ophthalmology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is MICHIGAN RETINA CENTER, PC (NPI: 1164960571; TIN: 384025028) and primary practice location at 48124-1715.

Tewari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,014 traditional Medicare patients, billed 48,600 HCPCS/CPT codes, and received $2,927,111 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,435 prescription claims across 664 beneficiaries totaling $43,993 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 37 records totaling $44,886. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,541,151 to $2,927,111. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$2.9M2015 Medicare payment: $1,541,151 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,605,978 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,403,533 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,846,125 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,144,269 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,983,380 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,394,886 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,539,746 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,826,122 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,927,111 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,16313,679$1,541,151
20161,24414,531$1,605,978
20171,08312,905$1,403,533
201892314,559$1,846,125
201999115,173$2,144,269
202089711,600$1,983,380
202193312,289$2,394,886
20221,01712,255$2,539,746
20231,08734,649$2,826,122
20241,01448,600$2,927,111

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$27K$54K2015 Drug cost: $53,951 (USD; Tot_Drug_Cst)2016 Drug cost: $36,482 (USD; Tot_Drug_Cst)2017 Drug cost: $36,574 (USD; Tot_Drug_Cst)2018 Drug cost: $36,523 (USD; Tot_Drug_Cst)2019 Drug cost: $32,729 (USD; Tot_Drug_Cst)2020 Drug cost: $36,834 (USD; Tot_Drug_Cst)2021 Drug cost: $40,242 (USD; Tot_Drug_Cst)2022 Drug cost: $40,424 (USD; Tot_Drug_Cst)2023 Drug cost: $51,690 (USD; Tot_Drug_Cst)2024 Drug cost: $43,993 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015377923$53,951
2016390929$36,482
2017351721$36,574
2018380818$36,523
2019396918$32,729
20204931,033$36,834
20215411,087$40,242
20225811,137$40,424
20236311,353$51,690
20246641,435$43,993

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3431,712$93
92014Established patient complete exam of visual system616950$93
92134Imaging of retina9552,729$32
92201Extended exam of the back part of the eye with retinal drawing6711,276$20
92202Extended exam of the back part of the eye with optic nerve drawing283498$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium251,441$12,180
ProlensaBromfenac Sodium21983$10,482
Gentamicin SulfateGentamicin Sulfate95018,195$7,823
Prednisolone AcetatePrednisolone Acetate1274,990$5,093
Ketorolac TromethamineKetorolac Tromethamine792,445$1,266

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.37$44,886Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Asheesh Tewari, MD?

Tedicare shows public-source Medicare data for Asheesh Tewari, MD (NPI 1043248032), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asheesh Tewari, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Asheesh Tewari, MD?

Asheesh Tewari, MD is linked to MICHIGAN RETINA CENTER, PC (billing NPI 1164960571) in the available physician profile data.

Does Asheesh Tewari, MD have Open Payments data?

Asheesh Tewari, MD has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.